[Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Austin, TX, USA, July 16, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'Ultomiris Drug Market Size, Trends and Insights By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)), By End-use (Adult, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' in its research database.
'According to the latest research study, the demand of the global Ultomiris Drug Market size & share was valued at approximately USD 4.16 Billion in 2024 and is expected to reach USD 5.47 Billion in 2025 and is expected to reach a value of around USD 64.12 Billion by 2034, at a compound annual growth rate (CAGR) of about 31.52% during the forecast period 2025 to 2034.'
Click Here to Access a Free Sample Report of the Global Ultomiris Drug Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=70951
Overview
As per the industry experts at CMI, the global ultomiris drug market will witness a whopping CAGR between 2025 and 2034. This could be attributed to the rise in demand for various long-acting treatments for rare disorders, especially paroxysmal nocturnal hemoglobinuria (PNH) and generalized myasthenia gravis (gMG). North America holds the largest market share due to speedy adoption of ultomiris drug by the U.S. and Canada. Hospital pharmacies dominate as far as distribution channels are concerned.
Key Trends & Drivers
Long-Acting Treatment Preference to Spell Growth: Ultomiris does offer a long-acting dosing interval (every 8 weeks), which enhances patient convenience and compliance as compared to the shorter-acting alternatives. Ultomiris is also known for demonstrating robust clinical performance along with a well-established safety profile.
Request a Customized Copy of the Ultomiris Drug Market Report @ https://www.custommarketinsights.com/request-for-customization/?reportid=70951
Approval by Regulatory Bodies to Catalyze Growth: The U.S. FDA had approved ultomiris for adults suffering from gMG in the year 2022. Since then, the drug has strengthened its position in the neurology sector. The FDA also conducted a review on priority in March 2024 for ultomiris in NMOSD. These approvals and reviews are bound to take the ultomiris market to the next level in the forecast period.
Report Scope
Feature of the Report
Details
Market Size in 2025
USD 5.47 Billion
Projected Market Size in 2034
USD 64.12 Billion
Market Size in 2024
USD 4.16 Billion
CAGR Growth Rate
31.52% CAGR
Base Year
2024
Forecast Period
2025-2034
Prominent Players
AstraZeneca, Xencor Inc., Chugai Pharmaceutical, Argenx, Alexion Pharmaceuticals, Others, and Others
Key Segment
By Indication, End-use, Distribution Channel and Region
Report Coverage
Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options
Request tailored purchasing options to fulfil your requirements for research.
(A free sample of the Ultomiris Drug report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the following:
Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report.
The COVID-19 Pandemic Outbreak Impact Analysis is included in the package.
About 220+ Pages Research Report (Including Recent Research)
Provide detailed chapter-by-chapter guidance on the Request.
Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025
Includes Tables and figures have been updated.
The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Custom Market Insights (CMI) research methodology
(Please note that the sample of the Ultomiris Drug report has been modified to include the COVID-19 impact study prior to delivery.)
Request a Customized Copy of the Ultomiris Drug Market Report @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
SWOT Analysis
Strengths: Ultomiris has demonstrated a manageable safety profile and efficacy in the treatment of gMG and PNH. With the market for rare disease therapies growing on the whole, a favorable environment is created for ultomiris. Also, ongoing research coupled with clinical trials is bound to result in extra approved indications for ultomiris drug, thereby bolstering its market potential.
Weaknesses: Ultomiris is quite expensive. This is likely to apply brakes to its accessibility for certain patients, particularly in the resource-limited settings. Moreover, the need for intravenous infusion could be a barrier to patient convenience and preference.
Opportunities: Ultomiris has a huge potential for growth in the emerging markets with expansion of healthcare infrastructure and awareness regarding rare diseases. Furthermore, a subcutaneous formulation on the part of ultomiris is likely to offer a convenient route of administration for the patients. Also, exploration of the potential of combining ultomiris with the other therapies for improving treatment outcomes could fetch more revenue.
Threats: There are pharmaceutical companies developing competing therapies for gMG and PNH, which is likely to erode the market share of ultomiris. Also, the development as well as the approval of ultomiris' biosimilar version is likely to adversely affect the market pricing and share.
Request a Customized Copy of the Ultomiris Drug Market Report @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
Key questions answered in this report:
What is the size of the Ultomiris Drug market and what is its expected growth rate?
What are the primary driving factors that push the Ultomiris Drug market forward?
What are the Ultomiris Drug Industry's top companies?
What are the different categories that the Ultomiris Drug Market caters to?
What will be the fastest-growing segment or region?
In the value chain, what role do essential players play?
What is the procedure for getting a free copy of the Ultomiris Drug market sample report and company profiles?
Key Offerings:
Market Share, Size & Forecast by Revenue | 2025−2034
Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends
Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions
Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Buy this Premium Ultomiris Drug Research Report | Fast Delivery Available - [220+ Pages] @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
Regional Perspective
The ultomiris drug market is classified into North America, Europe, Asia Pacific, and LAMEA.
North America
North America accounts for more than 40% of the market share, and the status quo is expected to remain unchanged during the forecast period. This could be credited to the U.S. being equipped with advanced diagnostic capabilities, which enable early detection as well as treatment of aHUS and PNH.
Switching to ultomiris from soliris is witnessing acceleration, which is supported by the former's dosing intervals. Speedy adoption of innovative therapies and strong clinical trial activity are bolstering the market further. Higher level of awareness amongst the healthcare professionals regarding rare diseases ascertains timely intervention and diagnosis. Preference for therapies with a reduction in treatment burden does favor ultomiris over its counterparts.
Asia Pacific
The Asia Pacific is expected to expand at the fastest CAGR in the ultomiris market due to the rise in the number of patients with rare diseases. Improvement in healthcare infrastructure does improve access to advanced treatments through diagnosis.
The structured approach toward rare disease management in Japan extends support to patient identification as well as treatment initiation. Integrating ultomiris into clinical practice does reflect the perceived benefits. Such elements do contribute to the presence of this drug in Japan.
China's expanding healthcare system and emphasis on rare diseases do contribute to the growth of ultomiris market. Efforts in the direction of improving diagnostic capabilities facilitate detection of aHUS and PNH earlier. Moreover, increasing familiarity of healthcare professionals with complement inhibitors lends support to the adoption of the drug.
Europe
Europe's ultomiris market is strongly supported by growing awareness as well as diagnosis regarding rare diseases. Of late, ultomiris has been approved for pediatric use regarding conditions such as PNH. Clinical recommendations and guidelines do endorse the usage of ultomiris in the patient population. This transition to ultomiris from the existing therapies does reflect the perceived benefits. The region's emphasis on improvement of patient quality of life does support adopting treatments needing lesser hospital visits.
LAMEA
In LAMEA, physicians are increasingly recommending longer-acting treatment for reducing clinical visits and improving patient compliance. The educational efforts are improving understanding of complement-mediated cases across all the markets. Though regulatory timelines could vary, frequency of approvals is expanding across various countries. partnerships and collaborations in the healthcare sector contribute to the development of the market.
Request a Customized Copy of the Ultomiris Drug Market Report @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
(We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)
Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media?
Email Directly Here with Detail Information: support@custommarketinsights.com
Browse the full 'Ultomiris Drug Market Size, Trends and Insights By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)), By End-use (Adult, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' Report at https://www.custommarketinsights.com/report/ultomiris-drug-market/
List of the prominent players in the Ultomiris Drug Market:
AstraZeneca
Xencor Inc.
Chugai Pharmaceutical
Argenx
Alexion Pharmaceuticals
Others
Click Here to Access a Free Sample Report of the Global Ultomiris Drug Market @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
Spectacular Deals
Comprehensive coverage
Maximum number of market tables and figures
The subscription-based option is offered.
Best price guarantee
Free 35% or 60 hours of customization.
Free post-sale service assistance.
25% discount on your next purchase.
Service guarantees are available.
Personalized market brief by author.
Browse More Related Reports:
Pet Oral Care Products Market: Pet Oral Care Products Market Size, Trends and Insights By Product Type (Toothbrush, Toothpaste, Mouthwash/Rinse, Dental Chews, Others), By Animal Type (Dogs, Cats, Others), By Application (Residential, Commercial), By Distribution Channel (Supermarkets and Hypermarkets, Online Stores, Specialized Pet Shops, Veterinary Channels), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
Magnesium Supplements Market: Magnesium Supplements Market Size, Trends and Insights By Type (Tablets, Capsules, Powders, Liquids), By Application (Dietary Supplements, Pharmaceuticals, Animal Feed, Others), By Distribution Channel (Online, Offline), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
Blockchain-Based Electronic Health Record Market: Blockchain-Based Electronic Health Record Market Size, Trends and Insights By Blockchain Type (Public Blockchain, Private Blockchain, Consortium/Permissioned Blockchain, Hybrid Blockchain), By Application (Patient Record Management, Clinical Trial Data Sharing, E-prescription & Medical Billing, Medical Imaging & Diagnostics, Insurance Claim & Fraud Detection, Remote Patient Monitoring (via IoMT)), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
AI in Synthetic Biology Market: AI in Synthetic Biology Market Size, Trends and Insights By Technology (Gene Synthesis, Genome Editing, Synthetic Biology Tools, Bioinformatics), By Application (Healthcare & Medicine, Agricultural Biotechnology, Industrial Biotechnology, Environmental Biotechnology), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
Advanced Genomics Market: Advanced Genomics Market Size, Trends and Insights By Offering (Products, Services), By Technology (Sequencing, PCR, Gene Editing, Flow Cytometry, Microarrays, In Situ Hybridization), By Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture), By End-user (Hospitals and Clinics, Research Centers, Pharmaceutical and Biotechnology Companies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034
Cell and Gene Therapy Market: Cell and Gene Therapy Market Size, Trends and Insights By Therapy Type (Cell Theray, Gene Therapy), By Therapeutic Class (Cardiovascular Disease, Cancer, Genetic Disorder, Rare Diseases, Oncology, Hematology, Ophthalmology, Infectious Disease, Neurological Disorders, Others), By Delivery Method (In Vivo, Ex Vivo), By End-User (Hospitals, Cancer Care Centers, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
Battery-Free Implants Market: Battery-Free Implants Market Size, Trends and Insights By Product Type (Neural Implants, Cardiac Implants , Cochlear Implants, Orthopedic Implants, Others), By Technology (Energy Harvesting, Wireless Power Transfer, RFID/NFC-based Systems), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutions, Specialty Clinics), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
Alzheimer's Drug Market: Alzheimer's Drug Market Size, Trends and Insights By Type of Drug (Disease-Modifying Therapies (DMTs), Symptomatic Therapies), By Application (Amyloid-Targeting Agents, Tau-Targeting Agents, Cholinesterase Inhibitors, NMDA Antagonists, Other Agents), By End User (Hospitals, Clinics, Home Care Settings), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
The Ultomiris Drug Market is segmented as follows:
By Indication
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Atypical Hemolytic Uremic Syndrome (aHUS)
Generalized Myasthenia Gravis (gMG)
Neuromyelitis Optica Spectrum Disorder (NMOSD)
By End-use
Adult
Pediatric
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Click Here to Get a Free Sample Report of the Global Ultomiris Drug Market @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
Regional Coverage:
North America
U.S.
Canada
Mexico
Rest of North America
Europe
Germany
France
U.K.
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
New Zealand
Australia
South Korea
Taiwan
Rest of Asia Pacific
The Middle East & Africa
Saudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
This Ultomiris Drug Market Research/Analysis Report Contains Answers to the following Questions.
Which Trends Are Causing These Developments?
Who Are the Global Key Players in This Ultomiris Drug Market? What are Their Company Profile, Product Information, and Contact Information?
What Was the Global Market Status of the Ultomiris Drug Market? What Was the Capacity, Production Value, Cost and PROFIT of the Ultomiris Drug Market?
What Is the Current Market Status of the Ultomiris Drug Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of Ultomiris Drug Market by Considering Applications and Types?
What Are Projections of the Global Ultomiris Drug Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports?
What Is Ultomiris Drug Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
What Is the Economic Impact On Ultomiris Drug Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
What Are Market Dynamics of Ultomiris Drug Market? What Are Challenges and Opportunities?
What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Ultomiris Drug Industry?
Click Here to Access a Free Sample Report of the Global Ultomiris Drug Market @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
Reasons to Purchase Ultomiris Drug Market Report
Ultomiris Drug Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors.
Ultomiris Drug Market report outlines market value (USD) data for each segment and sub-segment.
This report indicates the region and segment expected to witness the fastest growth and dominate the market.
Ultomiris Drug Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region.
The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled.
Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players.
The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions.
Ultomiris Drug Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain.
Reasons for the Research Report
The study provides a thorough overview of the global Ultomiris Drug market. Compare your performance to that of the market as a whole.
Aim to maintain competitiveness while innovations from established key players fuel market growth.
Buy this Premium Ultomiris Drug Research Report | Fast Delivery Available - [220+ Pages] @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
What does the report include?
Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Ultomiris Drug market analysis.
The competitive environment of current and potential participants in the Ultomiris Drug market is covered in the report, as well as those companies' strategic product development ambitions.
According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions.
For each segment mentioned above, actual market sizes and forecasts have been given.
Who should buy this report?
Participants and stakeholders worldwide Ultomiris Drug market should find this report useful. The research will be useful to all market participants in the Ultomiris Drug industry.
Managers in the Ultomiris Drug sector are interested in publishing up-to-date and projected data about the worldwide Ultomiris Drug market.
Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Ultomiris Drug products' market trends.
Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans.
Request a Customized Copy of the Ultomiris Drug Market Report @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
About Custom Market Insights:
Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.
CMI offers a comprehensive solution that covers everything from data collection to investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts utilize client insights to inform strategies for estimating future declines, forecasting opportunities for growth, and conducting consumer surveys.
Follow Us: LinkedIn | Twitter | Facebook | YouTube
Contact Us:
Joel John
CMI Consulting LLC
1333, 701 Tillery Street Unit 12,
Austin, TX, Travis, US, 78702
USA: +1 737-734-2707
India: +91 20 46022736
Email: support@custommarketinsights.com
Web: https://www.custommarketinsights.com/
Blog: https://www.techyounme.com/
Blog: https://businessresearchindustry.com
Blog: https://www.technowalla.com/
Blog: https://marketresearchtrade.com/
Buy this Premium Ultomiris Drug Research Report | Fast Delivery Available - [220+ Pages] @ https://www.custommarketinsights.com/report/ultomiris-drug-market/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Android Authority
2 minutes ago
- Android Authority
Get up to $350 to use in the Google Store when pre-ordering your new Pixel 10 phone
TL;DR Google's own pre-order deals for the Pixel 10 series are now live. Shoppers will get between $100 and $350 in Google Store credits depending on the Pixel 10 model they choose. Pre-orders must be made by September 4, and your credit will be applied when your order ships. Today Google introduces its latest Pixel 10 smartphones, and Android fans everywhere are no doubt feeling some serious temptation to pick one up. If you're going to take the plunge, though, we want to make sure you're getting the most bang for your buck — and that's exactly why you need to be aware of all the various pre-order promos being offered out there. Don't want to miss the best from Android Authority? Set us as a preferred source in Google Search to support us and make sure you never miss our latest exclusive reports, expert analysis, and much more. We already started looking at what the big US carriers are offering for Pixel 10 pre-orders, and now Google's own page of deals has gone live on the Google Store. If you're picking up a Pixel 10 Pro or Pixel 10 Pro XL, you'll be getting a $200 Google Store credit to use on a future purchase. Go for the base Pixel 10, and you can still snag a $100 credit. And for you fat cats splurging on the Pixel 10 Pro Fold, you've got $350 coming your way. Remember, to get these pre-order deals, you can't wait around forever, and you'll need to make your choice before September 4. Don't count on immediately redeeming that Google Store credit and tacking on a bunch of accessories — at least not yet — as Google won't be adding that to your account until your phone actually ships out to you. And if you need to sweeten the pot a little more, Google will offer you up to $760 in trade-in credit for your old phone. Follow
TechCrunch
2 minutes ago
- TechCrunch
Pixel 10, new Gemini features, the Pixel Watch, and everything else announced at the Made by Google 2025 event
The Made by Google 2025 event is finally happening, notably before Apple's hardware event is expected to take place in September. On Wednesday, the tech giant debuted its Pixel 10 series, a new foldable, the Pixel Watch 4, the second generation of the cost-friendly A-Series earbuds, generative AI capabilities with Gemini, and more. Get ready for a Gemini boost Image Credits:Thomas Fuller/SOPA Images/LightRocket / Getty Images Google already dropped several AI-related updates at its developer conference in May, but the company demonstrated more Gemini features during the Pixel 10 event. In a recent YouTube video promoting the new devices, Google even seemed to poke fun at Apple's failed promises with Apple Intelligence advancements on the iPhone. Gemini Live received an upgrade this year, so now when you ask questions, you can share your camera, and the assistant can follow along and guide you. For instance, sharing an image of your room with the AI and getting interior design ideas. Taking photos on the Pixel 10 also got a boost. A new feature called 'Camera Coach,' for example, lets Gemini give you real-time tips for taking better photos. The AI is able to see what's going on and suggest the best angles and lighting for your shot. In addition, there's a new conversational photo editing tool, where you tell Gemini what you want to tweak in a photo, such as increasing the brightness, removing objects, or changing the background. Pixel 10, 10 Pro, and 10 Pro XL Image Credits:Google The standard Pixel 10 phone underwent significant changes, particularly with the addition of a dedicated telephoto lens, a feature that was previously exclusive to the Pro models. Google released a teaser for the Pixel 10 prior to Wednesday's event. Techcrunch event Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $600+ before prices rise. Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. San Francisco | REGISTER NOW The company says the new 5x telephoto lens is its best zoom quality, and the 100x Pro Res Zoom allows for high-quality closeups. Additionally, all phones in the lineup are powered by a new Tensor G5 processor, ushering in the Gemini era and enhancing performance and power efficiency compared to the Tensor G4 chip. Aside from these updates, there weren't many obvious changes. The basic design of the phones remains similar to that of the Pixel 9 series. The displays are also staying the same, with the Pixel 10 and Pixel 10 Pro featuring a 6.3-inch display, and the Pixel 10 Pro XL with a larger 6.8-inch display. The Pro models also get improved camera and video quality, along with battery size, which allows for faster charging and finally addresses the longevity gap between Pixel and flagship phones from Apple and Samsung. PixelSnap Notably, the Pixel 10 devices have magnetic technology built into them thanks to 'PixelSnap,' the company's version of 'MagSafe.' Google released a line of magnetic accessories to pair with the lineup, including a new $40 Pixelsnap charger that supports Qi2 wireless charging. The company also launched a $50 phone case with a magnetic ring in the center and a $30 ring stand for hands-free use. Pixel 10 Pro Fold Image Credits:Google As for Google's latest foldable, it has a larger cover display, measuring at around 6.4 inches, alongside an 8-inch main screen. Google also enhanced the strength of the hinge, and the bezels are thinner for a sleek appearance. Another exciting addition is an IP68 rating, a first for the device. This means it can stand up to both dust and water, whereas the Pixel 9 Pro Fold has zero dust protection. Like the other Pixel 10 phones, the Pro Fold is powered by the new G5 chip and includes the latest Gemini AI features. The camera system also received improvements, potentially featuring a 48-megapixel ultra-wide lens and a telephoto lens with 5x optical zoom. The phone also saw an improvement in battery life. The Pixel 10 Pro Fold costs $1,799 and is available in Moonstone and Jade colors. Pixel Journal app Image Credits:Google The tech giant is coming for Apple's Journal app with Pixel Journal, a new journaling app for Pixel 10 devices. With the app, you can write entries, add photos, locations, and activities, as well as lock entries for privacy. The app also includes AI features, such as prompt suggestions to spark inspiration. The Pixel Watch and Pixel Buds Image Credits:Google Wearables will also get their time to shine at Google's event, with the Pixel Watch 4 getting a thicker design, a longer battery life, and smaller bezels. The smartwatch also introduced its own AI capabilities, such as the ability to access Gemini by lifting your wrist. The Pixel Buds 2a offer a much-needed upgrade from the first generation of the A-Series earbuds, coming with active noise cancellation and fun new colors: Hazel and Iris. The Pixel Buds Pro 2 introduced a new Gemini feature for answering calls with gestures and comes in a new Moonstone color. Fitbit gets an AI-powered health coach Image Credits:Google Google announced a new AI personal health coach for the Fitbit fitness tracking app. This feature allows users to create customized workout routines by discussing their goals, preferences, and available equipment. The AI coach generates a personalized fitness plan with workout suggestions and adjusts plans in real-time based on user data to help achieve fitness goals. The AI trainer also acts as a sleep coach, providing insights into how to improve your sleep quality. A preview of the AI coach will be available in October. It will be integrated into the redesigned Fitbit app and will work with the latest Fitbit trackers, smartwatches, and Pixel Watches. This story has been updated after publication. We're always looking to evolve, and by providing some insight into your perspective and feedback into TechCrunch and our coverage and events, you can help us! Fill out this survey to let us know how we're doing and get the chance to win a prize!
Bloomberg
2 minutes ago
- Bloomberg
Blackstone's Perry Sees Secondaries Topping $400 Billion by 2030
Blackstone Inc. 's Verdun Perry called buying and selling existing stakes of private assets 'the most underutilized tool' in that market, predicting secondaries deal volume will more than double to $400 billion by 2030. 'Whether it's a slow market or a robust market, the secondary role is going to increase over time as a solution to private market investors,' Perry, the head of Blackstone's secondaries business, said in an interview Wednesday for Bloomberg TV.
